These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

801 related items for PubMed ID: 18599020

  • 1. Tumor anti-angiogenic effect and mechanism of action of delta-tocotrienol.
    Shibata A, Nakagawa K, Sookwong P, Tsuzuki T, Oikawa S, Miyazawa T.
    Biochem Pharmacol; 2008 Aug 01; 76(3):330-9. PubMed ID: 18599020
    [Abstract] [Full Text] [Related]

  • 2. Anti-angiogenic function of tocotrienol.
    Miyazawa T, Shibata A, Nakagawa K, Tsuzuki T.
    Asia Pac J Clin Nutr; 2008 Aug 01; 17 Suppl 1():253-6. PubMed ID: 18296349
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of the phosphatidylinositol 3-kinase/Akt pathway by inositol pentakisphosphate results in antiangiogenic and antitumor effects.
    Maffucci T, Piccolo E, Cumashi A, Iezzi M, Riley AM, Saiardi A, Godage HY, Rossi C, Broggini M, Iacobelli S, Potter BV, Innocenti P, Falasca M.
    Cancer Res; 2005 Sep 15; 65(18):8339-49. PubMed ID: 16166311
    [Abstract] [Full Text] [Related]

  • 4. delta-Tocotrienol suppresses VEGF induced angiogenesis whereas alpha-tocopherol does not.
    Shibata A, Nakagawa K, Sookwong P, Tsuduki T, Oikawa S, Miyazawa T.
    J Agric Food Chem; 2009 Sep 23; 57(18):8696-704. PubMed ID: 19702331
    [Abstract] [Full Text] [Related]

  • 5. γ-Tocotrienol inhibits angiogenesis of human umbilical vein endothelial cell induced by cancer cell.
    Li Y, Sun WG, Liu HK, Qi GY, Wang Q, Sun XR, Chen BQ, Liu JR.
    J Nutr Biochem; 2011 Dec 23; 22(12):1127-36. PubMed ID: 21292465
    [Abstract] [Full Text] [Related]

  • 6. Antiangiogenic potency of vitamin E.
    Miyazawa T, Tsuzuki T, Nakagawa K, Igarashi M.
    Ann N Y Acad Sci; 2004 Dec 23; 1031():401-4. PubMed ID: 15753181
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Pseudolarix acid B inhibits angiogenesis by antagonizing the vascular endothelial growth factor-mediated anti-apoptotic effect.
    Tan WF, Zhang XW, Li MH, Yue JM, Chen Y, Lin LP, Ding J.
    Eur J Pharmacol; 2004 Sep 24; 499(3):219-28. PubMed ID: 15381043
    [Abstract] [Full Text] [Related]

  • 10. Arachidonic acid epoxygenase metabolites stimulate endothelial cell growth and angiogenesis via mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signaling pathways.
    Wang Y, Wei X, Xiao X, Hui R, Card JW, Carey MA, Wang DW, Zeldin DC.
    J Pharmacol Exp Ther; 2005 Aug 24; 314(2):522-32. PubMed ID: 15840765
    [Abstract] [Full Text] [Related]

  • 11. Barbigerone, an isoflavone, inhibits tumor angiogenesis and human non-small-cell lung cancer xenografts growth through VEGFR2 signaling pathways.
    Li X, Wang X, Ye H, Peng A, Chen L.
    Cancer Chemother Pharmacol; 2012 Sep 24; 70(3):425-37. PubMed ID: 22814678
    [Abstract] [Full Text] [Related]

  • 12. Tocotrienol inhibits secretion of angiogenic factors from human colorectal adenocarcinoma cells by suppressing hypoxia-inducible factor-1alpha.
    Shibata A, Nakagawa K, Sookwong P, Tsuduki T, Tomita S, Shirakawa H, Komai M, Miyazawa T.
    J Nutr; 2008 Nov 24; 138(11):2136-42. PubMed ID: 18936210
    [Abstract] [Full Text] [Related]

  • 13. Anti-angiogenic effect of furanodiene on HUVECs in vitro and on zebrafish in vivo.
    Zhong ZF, Hoi PM, Wu GS, Xu ZT, Tan W, Chen XP, Cui L, Wu T, Wang YT.
    J Ethnopharmacol; 2012 Jun 01; 141(2):721-7. PubMed ID: 21911050
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of the tyrosine phosphatase SHP-2 suppresses angiogenesis in vitro and in vivo.
    Mannell H, Hellwig N, Gloe T, Plank C, Sohn HY, Groesser L, Walzog B, Pohl U, Krotz F.
    J Vasc Res; 2008 Jun 01; 45(2):153-63. PubMed ID: 17962719
    [Abstract] [Full Text] [Related]

  • 15. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
    Zhang GM, Zhang YM, Fu SB, Liu XH, Fu X, Yu Y, Zhang ZY.
    Chin Med J (Engl); 2008 Nov 20; 121(22):2324-30. PubMed ID: 19080341
    [Abstract] [Full Text] [Related]

  • 16. The transforming growth factor-beta family members bone morphogenetic protein-2 and macrophage inhibitory cytokine-1 as mediators of the antiangiogenic activity of N-(4-hydroxyphenyl)retinamide.
    Ferrari N, Pfeffer U, Dell'Eva R, Ambrosini C, Noonan DM, Albini A.
    Clin Cancer Res; 2005 Jun 15; 11(12):4610-9. PubMed ID: 15958647
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The vascular targeting property of paclitaxel is enhanced by SU6668, a receptor tyrosine kinase inhibitor, causing apoptosis of endothelial cells and inhibition of angiogenesis.
    Naumova E, Ubezio P, Garofalo A, Borsotti P, Cassis L, Riccardi E, Scanziani E, Eccles SA, Bani MR, Giavazzi R.
    Clin Cancer Res; 2006 Mar 15; 12(6):1839-49. PubMed ID: 16551869
    [Abstract] [Full Text] [Related]

  • 19. Anti-angiogenic action of plasma hyaluronan binding protein in human umbilical vein endothelial cells.
    Jeon JW, Song HS, Moon EJ, Park SY, Son MJ, Jung SY, Kim JT, Nam DH, Choi-Miura NH, Kim KW, Kim YJ.
    Int J Oncol; 2006 Jul 15; 29(1):209-15. PubMed ID: 16773202
    [Abstract] [Full Text] [Related]

  • 20. Hispidulin, a small flavonoid molecule, suppresses the angiogenesis and growth of human pancreatic cancer by targeting vascular endothelial growth factor receptor 2-mediated PI3K/Akt/mTOR signaling pathway.
    He L, Wu Y, Lin L, Wang J, Wu Y, Chen Y, Yi Z, Liu M, Pang X.
    Cancer Sci; 2011 Jan 15; 102(1):219-25. PubMed ID: 21087351
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.